Two 26-week, double blind, placebo-controlled clinical studies have established that rosiglitazone monotherapy reduces fasting plasma glucose and HbA1c in patients with type 2 diabetes [148][149]
While using the medication, she lost 20 pounds, but she didnt want to be on medication forever
Still, many healthcare providers might not prescribe tirzepatide as a first-line treatment for Type 2 diabetes due to costs and available alternatives
For patients who have tolerated the 2.4 mg injection for at least four weeks and need additional weight loss support, a higher-dose option Wegovy HD (7.2 mg) was FDA-approved in March 2026
Chocolate (370 mentions), eggs (297), and protein shakes (223) rounded out the top five
So, What Exactly Are GLP-1 Patches